Phase 2 Prostatic Neoplasms, Castration-Resistant trials recruiting now

All Prostatic Neoplasms, Castration-Resistant trials, every phase

Other phases for Prostatic Neoplasms, Castration-Resistant

Phase 2 Prostatic Neoplasms, Castration-Resistant trials

• 64Cu-SAR-bisPSMA and 67Cu-SAR-bisPSMA for Identification and Treatment of PSMA-expressing Metastatic Castrate Resistant Prostate Cancer (SECuRE)
  NCT04868604 · Phase: Phase 1, Phase 2 · Ages: 18 Years and older · Sex: Male · 7 locations
• A Study of Tulmimetostat DZR123 (CPI-0209) in Patients With Advanced Solid Tumors and Lymphomas
  NCT04104776 · Phase: Phase 1, Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · 160 locations
• Fractionated Stereotactic Radiotherapy Plus Second-generation Antiandrogen for Oligometastatic Castration-resistant Prostate Cancer Patients.
  NCT07717268 · Phase: Phase 2 · Ages: No age limits stated · Sex: Male · 15 locations
• Gedatolisib in Combination With Darolutamide in Metastatic Castration-Resistant Prostate Cancer
  NCT06190899 · Phase: Phase 1, Phase 2 · Ages: 18 Years and older · Sex: Male · 13 locations
• HTL0039732 in Participants With Advanced Solid Tumours
  NCT05944237 · Phase: Phase 1, Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · 10 locations
• Phase II Randomised Controlled Trial of Patient-specific Adaptive vs. Continuous Abiraterone or eNZalutamide in mCRPC
  NCT05393791 · Phase: Phase 2 · Ages: 18 Years and older · Sex: Male · 19 locations
• Substudy 01A: Safety and Efficacy of Opevesostat (MK-5684)-Based Treatment Combinations or Opevesostat Alone in Participants With Metastatic Castration-resistant Prostate Cancer (mCRPC) (MK-5684-01A)
  NCT06353386 · Phase: Phase 1, Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · 77 locations

Common questions

What does Phase 2 mean?

See how clinical trials work.

Is this list complete?

No. For the full record, search ClinicalTrials.gov.